LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response
NCT07459959
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer s Disease
Interventions
DRUG:
Lithium orotate
DRUG:
Matched Placebo (Capsules)
Sponsor
Johns Hopkins University
Collaborators
[object Object]